课题基金 / 基金详情

Protein Dephosphorylation and Apoptosis in Osteoblast

Protein Dephosphorylation and Apoptosis in Osteoblast
成骨细胞中的蛋白质去磷酸化和细胞凋亡
批准号:
09671860
负责人:
HANEJI Tatsuji
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

HANEJI Tatsuji的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Phosphorylation and dephosphorylation play a central role in the regulation of cellular proliferation and differentiation. It seems likely that the balance between these activities also plays an important parts in apoptosis. Okadaic acid (OA) is a potent inhibitor of protein phosphatases type 1 (PP-1) and type 2A (PP-2A) and increases the phosphorylation of cellular proteins without activation of protein kinase C.We demonstrated that OA induces apoptosis in both Saos-2 cells and MG63 cells in a dose-dependent manner with a maximum effective concentration of 10 nM (Morimoto et al, 1997). Because inhibition of protein phosphatase activity by OA may be a general way of triggering apoptosis in some kinds of cells, it is believed that new protein synthesis is not required for OA-induced apoptosis.To determine if inhibition of the protein synthesis or RNA synthesis could protect against the OA-induced apoptosis in osteoblasts, we cultured the cells in media containing varying concentrations of cycloheximide, actinomycin D, or puromycin in the presence of 10 nM OA.Cycloheximide, actinomycin D, and puromycin significantly protected against OA-induced cytotoxicity and cell death in MG63 cells. The number of apoptotic cells examined by the Hoechst 33342 staining also significantly decreased in MG63 cells treated with these reagents in the presence of OA.Moreover, the intensity of DNA ladder formation was decreased in MG63 cells treated with these reagents in a dose-dependent manner. The maximum effective concentrations of these reagents on the protection of OA-induced apoptosis in MG63 cells are in good agreement with the data concerning thier biological effects in other systems. However, cycloheximide, actinomycin D, and puromycin did not protect against the OA-induced apoptotic cell death in Saos-2 cells determined by the morphological and biochemical techniques (Morimoto et al, in press).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Haneji, T., Morimoto, H., Morimoto, Y., Shirakawa, S., Kobayashi, S., Kaneda, C., Shima, H.and Nagao, M: "Subcellular localization of protein phosphatase type1 isotypes in mouse osteoblastic cells." Biochemical and Biophysical Research Communications. 248
Haneji, T.、Morimoto, H.、Morimoto, Y.、Shirakawa, S.、Kobayashi, S.、Kaneda, C.、Shima, H. 和 Nagao, M:“小鼠成骨细胞中蛋白磷酸酶 1 型同种型的亚细胞定位
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tamura, H., Mochizuki, H., Takehara, T., Kobayashi, S.and Haneji, T.: "Variability of argyrophilic nucleolar organizer regions in osteoblastic cells." The Journal of Kyushu Dental Society. 51. 623-628 (1997)
Tamura, H.、Mochizuki, H.、Takehara, T.、Kobayashi, S. 和 Haneji, T.:“成骨细胞中嗜银核仁组织者区域的变异性。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
12
    The role of PKR on the differentiation of osteoblasts and formation of osteoclasts
    • 批准号:
      25462859
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2013
    • 负责人:
      HANEJI Tatsuji
    • 依托单位:
    The role of PKR, Osterix, and Calcineurin in osteogenesis
    • 批准号:
      21592330
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2009
    • 负责人:
      HANEJI Tatsuji
    • 依托单位:
    Elucidation of the mechanisms of okadaic acid-induced apoptosis and cleavage of nucleolar proteins in osteoblasts
    • 批准号:
      17591915
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2005
    • 负责人:
      HANEJI Tatsuji
    • 依托单位:
    Protein phosphatases and cleavage of nucleolin in apoptosis-induced osteoblastic cells
    • 批准号:
      15591936
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2003
    • 负责人:
      HANEJI Tatsuji
    • 依托单位:
    国内基金
    海外基金
    Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
    • 批准号:
      LBY21H010001
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      郑绪阳
    • 依托单位:
    去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
    • 批准号:
      31970691
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2019
    • 负责人:
      张胜萍
    • 依托单位:
    TM9SF4调控非小细胞肺癌细胞凋亡机制研究
    • 批准号:
      31900527
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2019
    • 负责人:
      孙磊
    • 依托单位:
    基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
    • 批准号:
      81703335
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卫高菲
    • 依托单位: